CDEK
← All organizations

VBI Vaccines Inc.

For profitWebsite ↗

Also known as: Variation Biotechnologies Inc. | VBI Vaccines | VBI Vaccines (Delaware), Inc. | VBI Vaccines Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Mar 2, 2006

First marketed drug

Nov 30, 2021

Last known activity

Mar 31, 2023

Timeline

2000s

  1. Jun 1, 2001

    VBI Vaccines Inc.— Founded

2010s

  1. Sep 15, 2011

    Epixis— Acquired

  2. May 9, 2016

    SciVac Therapeutics— Acquired

2020s

  1. Nov 30, 2021

    hepatitis b vaccine (recombinant)— NDA Secondary Org

Drugs by trial phase (9 distinct, 11 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (5 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (14)

Details

Founded
Cambridge, MA, US Jun 1, 2001
Last known activity
Mar 31, 2023